Respiratory Failures Software For Clinical Medicine
-
based in USA
We are conducting a multicenter, double-blinded, randomized, placebo-controlled trial for ARDS due to COVID-19 or influenza virus infection. ARDS can be rapidly induced by a variety of insults, such as coronavirus and influenza virus infection. Approximately 150,000 people experience ARDS in the U.S. annually, with a mortality rate of about 40%. These numbers are increasing as a result of ...
-
by Strados Labsbased in USA
Our respiratory management solution enables real-world, real-time measuring of lung health by harnessing the power of smart sensor technologies. The RESP™ Smart Sensor Platform collects and calculates the frequency of wheezing, coughing, shortness of breath, as well as respiratory dynamics like rate and excursion for a more holistic picture of each patient’s respiratory heath ...
-
based in USA
The IVCO2 Index provides a continuous risk estimation of inadequate ventilation or hypercapnia. The Index uses mathematical models of human physiology to determine the likelihood that the patient is experiencing inadequate carbon dioxide ventilation. The algorithm also estimates the mismatch between lung ventilation and perfusion, accounting for differences that can occur between EtCO2 values and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you